Surgical Science Sweden AB (publ) (STO: SUS)
122.30
-1.70 (-1.37%)
Sep 2, 2024, 10:41 AM CET
SUS Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 197.72 | 233.97 | 187.97 | 86.25 | 15.61 | 12.6 | Upgrade
|
Depreciation & Amortization | 40.38 | 38.4 | 35.66 | 23.9 | 10.25 | 7.23 | Upgrade
|
Other Amortization | 17.21 | 17.21 | 15.93 | 9.62 | 6.73 | 7.96 | Upgrade
|
Other Operating Activities | -43.22 | -45.64 | -44.46 | -34 | -3.52 | 1.84 | Upgrade
|
Change in Accounts Receivable | -31.55 | 31.91 | -70.76 | -84.57 | 1.86 | 22.98 | Upgrade
|
Change in Inventory | 2.67 | -19.57 | -21.72 | 6.46 | -5.27 | -2.44 | Upgrade
|
Change in Other Net Operating Assets | -32.04 | -17.99 | 26.87 | 31.43 | -2.43 | 5.03 | Upgrade
|
Operating Cash Flow | 151.18 | 238.29 | 129.49 | 39.08 | 23.23 | 55.2 | Upgrade
|
Operating Cash Flow Growth | -35.28% | 84.03% | 231.31% | 68.28% | -57.93% | 702.59% | Upgrade
|
Capital Expenditures | -9.76 | -10.46 | -9.35 | -3.87 | -0.4 | -0.32 | Upgrade
|
Cash Acquisitions | - | - | - | -2,718 | - | -201.39 | Upgrade
|
Sale (Purchase) of Intangibles | -40.95 | -33.67 | -25.2 | -10.51 | -8.3 | -8.59 | Upgrade
|
Investing Cash Flow | -50.71 | -44.13 | -34.55 | -2,733 | -8.69 | -210.3 | Upgrade
|
Long-Term Debt Issued | - | - | 17.09 | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -3.3 | - | -31.72 | -5.14 | -4.07 | Upgrade
|
Total Debt Repaid | -5.34 | -3.3 | - | -31.72 | -5.14 | -4.07 | Upgrade
|
Net Debt Issued (Repaid) | -5.34 | -3.3 | 17.09 | -31.72 | -5.14 | -4.07 | Upgrade
|
Issuance of Common Stock | - | - | - | 3,039 | 7.86 | 200 | Upgrade
|
Other Financing Activities | - | 19.15 | - | -84.87 | 1.49 | -10.15 | Upgrade
|
Financing Cash Flow | -5.34 | 15.85 | 17.09 | 2,922 | 4.21 | 185.78 | Upgrade
|
Foreign Exchange Rate Adjustments | -2.49 | -9.38 | 5.02 | 0.59 | -0.8 | 0.04 | Upgrade
|
Net Cash Flow | 92.66 | 200.63 | 117.05 | 229.52 | 17.94 | 30.72 | Upgrade
|
Free Cash Flow | 141.43 | 227.84 | 120.14 | 35.21 | 22.83 | 54.88 | Upgrade
|
Free Cash Flow Growth | -36.79% | 89.65% | 241.18% | 54.26% | -58.41% | 918.94% | Upgrade
|
Free Cash Flow Margin | 16.87% | 25.81% | 14.97% | 9.60% | 21.78% | 54.06% | Upgrade
|
Free Cash Flow Per Share | 2.77 | 4.47 | 2.36 | 0.83 | 0.66 | 1.89 | Upgrade
|
Cash Income Tax Paid | 14.4 | 14.55 | 8.48 | 3.43 | 9.07 | 0.68 | Upgrade
|
Levered Free Cash Flow | 19.32 | 95.48 | 95.86 | 17.79 | 10.32 | 17.13 | Upgrade
|
Unlevered Free Cash Flow | 19.32 | 95.88 | 96.19 | 18.11 | 10.65 | 17.19 | Upgrade
|
Change in Net Working Capital | 83.74 | 35.16 | 18.88 | 52.89 | 10.99 | -1.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.